Tonix Pharmaceuticals Holding Corp. (TNXP) Net income 2016–2025
Tonix Pharmaceuticals Holding Corp. (TNXP) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$124.0MFY2025 · since FY2016: -$38.8M → -$124.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$124.0M | +4.6% |
| FY2024 | -$130.0M | -11.5% |
| FY2023 | -$116.7M | -5.8% |
| FY2022 | -$110.2M | -19.4% |
| FY2021 | -$92.3M | -82.9% |
| FY2020 | -$50.5M | -76.3% |
| FY2019 | -$28.6M | -9.7% |
| FY2018 | -$26.1M | -23.5% |
| FY2017 | -$21.1M | +45.6% |
| FY2016 | -$38.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice